Agilent Q4 Revenues Inch up 2 Percent; Dako Drives Dx Growth | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent Technologies said after the close of the market on Monday that revenues for its Fiscal Year 2012 fourth quarter increased 2 percent year over year.

Total revenues for the three months ended Oct. 31 rose to $1.77 billion from $1.73 billion a year ago, edging out the average analyst estimate of $1.76 billion. Orders during the quarter were flat at $1.75 million.

"The headline for this quarter is that most of our end markets remained soft," Agilent CEO Bill Sullivan said on a conference call after the release of the company's earnings.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.